Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STIMULATE: Aranesp for Anemia in Elderly CKD Patients
NCT00364845Phase 3Terminated
- Sponsor
- Amgen
- Start
- Sep 2006
- Primary completion
- Dec 2008
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Amgen. Started Sep 2006; status: terminated.
02
Drugs
darbepoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00364845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364845.